Mycophenolate mofetil has potent anti-inflammatory actions in a mouse model of acute lung injury

Inflammation

Volumn 36, Issue 3, 2013, Pages 729-737

  Beduschi, M G ^a   Guimaraes C L ^a   Buss, Z S ^b   Dalmarco, E M ^b  

^a REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

acute lung injury; anti inflammatory; lipopolysaccharide; mice; mycophenolate mofetil

Indexed keywords

ADENOSINE DEAMINASE; DEXAMETHASONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ACUTE LUNG INJURY; ADENOSINE DEAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL MOVEMENT; DEXAMETHASONE; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-1BETA; LEUKOCYTES; LIPOPOLYSACCHARIDES; LUNG; MICE; MYCOPHENOLIC ACID; NITRIC OXIDE; PEROXIDASE; RNA, MESSENGER; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84877777714     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9599-x     Document Type: Article

References (33)

1. Alsberg, C.L., and O.F. Black. 1913. Contribution to the study of maize deterioration: Biochemical and toxicological investigations of Penicillium puberulum and Penicillium stoloniferum. Bull Burl Anim Ind US Dept Agr 270: 1-47.
2. Orvis, A.K., S.K. Wesson, T.S. Breza Jr., A.A. Church, C.L. Mitchell, and S.W. Watkins. 2009. Mycophenolate mofetil in dermatology. Journal of the American Academy of Dermatology 60: 183-199.
3. Dalal, P., M. Grafals, D. Chhabra, and L. Gallon. 2009. Mycophenolate mofetil: Safety and efficacy in the prophylaxis of acute kidney transplantation rejection. Therapeutics and Clinical Risk Management 5: 139-149.
4. Sollinger, H.W. 2004. Mycophenolates in transplantation. Clinical Transplantation 18: 485-492.
5. Allison, A.C., and E.M. Eugui. 2005. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80(2 Suppl): S181-S190.
6. Sahin, G.M., S. Sahin, G. Kantarci, and H. Ergin. 2007. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies. Nephrology (Carlton, Vic.) 12: 285-288.
7. Sinclair, A., G. Appel, M.A. Dooley, E. Ginzler, D. Isenberg, D. Jayne, D. Wofsy, and N. Solomons. 2007. Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: Rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). Lupus 16: 972-980.
8. Heatwole, C., and E. Ciafaloni. 2008. Mycophenolate mofetil for myasthenia gravis: A clear and present controversy. Neuropsychiatric Disease and Treatment 4: 1203-1209.
9. Aggarwal, R., and C.V. Oddis. 2011. Therapeutic approaches in myositis. Current Rheumatology Reports 13: 182-191.
10. Van Amersfoort, E.S., T.J. Van Berkel, and J. Kuiper. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clinical Microbiology Reviews 16: 379-414.
11. Dalmarco, E.M., C.M.M. Córdova, and T.S. Fröde. 2011. Evidence of an anti-inflammatory effect of mycophenolate mofetil in a murine model of pleurisy. Experimental Lung Research 37: 399-407.
12. Dalmarco, E.M., G. Astolfi, R. de Liz, C.M.M. Córdova, and T.S. Fröde. 2012. Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model. International Immunopharmacology 13: 476-482.
13. Bhattacharyya, S., A. Borthakur, S. Tyagi, R. Gill, M.L. Chen, P.K. Dudeja, and J.K. Tobacman. 2010. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kB production by both canonical and noncanonical pathways and for NF-kB-inducing kinase (NIK) phosphorylation. Journal of Biological Chemistry 285: 522-530.
14. McGhan, L.J., and D.E. Jaroszewski. 2012. The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury 43: 129-136.
15. Rao, T.S., J.L. Currie, A.F. Shaffer, and P.C. Isakson. 1993. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17: 723-741.
16. Giusti, G., and B. Galanti. 1984. Adenosine-deaminase: Colorimetric method. In Methods of enzymatic analyses, 3rd ed, ed. H.U. Bergmeyer, 315-323. Weinheim: Verlang Chemie Press.
17. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite and [15 N]nitrate in biological fluids. Analytical Biochemistry 126: 131-138.
18. Miranda, K.M., M.G. Espey, and D.A. Wink. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5: 62-71.
19. Nguyen, H.B., E.P. Rivers, F.M. Abrahamian, G.J. Moran, E. Abraham, S. Trzeciak, D.T. Huang, T. Osborn, D. Stevens, and D.A. Talan. 2006. Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: Review of the Literature and Emergency Department and Management Guidelines. Annals of Emergency Medicine 48: 28-54.
20. Hayashi, S., T. Yamada, M. Tsuneto, T. Yamane, M. Takahashi, L.D. Shultz, and H. Yamazaki. 2003. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. Journal of Immunology 171: 5130-5130.
21. Shin, E.S., H.J. Hwang, I.H. Kim, and T.J. Nam. 2011. A glycoprotein from Porphyra yezoensis produces anti-inflammatory effects in liposaccharide- stimulated macrophages via the TLR4 signaling pathway. International Journal of Molecular Medicine 28: 809-815.
22. Ronco, C., P. Piccini, and M.H. Rosner. 2010. Endotoxemia and endotoxin shock: Disease, diagnosis and therapy. Contributions to Nephrology 167: 1-13.
23. Opal, S.M. 2007. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. International Journal of Medical Microbiology 297: 365-377.
24. Dellinger, R.P., J.M. Carlet, H. Masur, H. Gerlach, T. Calandra, J. Cohen, J. Gea-Banacloche, D. Keh, J.C. Marshall, M.M. Parker, G. Ramsay, J.L. Zimmerman, J.L. Vincent, and M.M. Levy. 2004. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Medicine 30: 536-555.
25. Boyer, A., K. Chadda, A. Salah, and D. Annane. 2006. Glucocorticoid treatment in patients with septic shock: Effects on vasopressor use and mortality. International Journal of Clinical Pharmacology and Therapeutics 44: 309-318.
26. Salomão, R., P.S. Martins, M.K. Brunialti, M.L. Fernandes, L.S. Martos, M.E. Mendes, N.E. Gomes, and O. Rigato. 2008. TLR signaling pathway in patients with sepsis. Shock 30(Suppl 1): 73-77.
27. Fröde, T.S., and Y.S. Medeiros. 2001. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators of Inflammation 10: 223-227.
28. Lau, D., and S. Baldus. 2006. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacology and Therapeutics 111: 16-126.
29. Farivar, A.S., B. MacKinnon-Patterson, A.D. Barnes, and M.S. Mulligan. 2005. The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury. The Journal of Heart and Lung Transplantation 24: 2235-2242.
30. Cauwels, A. 2007. Nitric oxide in shock. Kidney International 72: 557-565.
31. Cuzzocrea, S., E. Mazzon, G. Calabro, L. Dugo, A. De Sarro, F.A. van De Loo, and A.P. Caputi. 2000. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. American Journal of Respiratory and Critical Care Medicine 162: 1859-1866.
32. Jonsson, C.A., and H. Carlsten. 2002. Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages. Cellular Immunology 216: 93-101.
33. Wu, Y., J. Dong, L. Yuan, C. Liang, K. Ren, W. Zhang, F. Fang, and J. Shen. 2008. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 44: 85-91.